Stock Analysis

Ondo InsurTech Decline Means Insider Profits Down To UK£80k

LSE:ONDO
Source: Shutterstock

Insiders who bought Ondo InsurTech Plc (LON:ONDO) in the last 12 months may probably not pay attention to the stock's recent 11% drop. After taking the recent loss into consideration, the UK£74.8k worth of stock they bought is now worth UK£154.5k, indicating that their investment yielded a positive return.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Advertisement

Ondo InsurTech Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Non-Executive Chairman Gregory Wood bought UK£49k worth of shares at a price of UK£0.15 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of UK£0.30. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

Happily, we note that in the last year insiders paid UK£75k for 510.80k shares. But insiders sold 137.93k shares worth UK£20k. Overall, Ondo InsurTech insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

View our latest analysis for Ondo InsurTech

insider-trading-volume
LSE:ONDO Insider Trading Volume March 28th 2025

Ondo InsurTech is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. From our data, it seems that Ondo InsurTech insiders own 12% of the company, worth about UK£4.6m. However, it's possible that insiders might have an indirect interest through a more complex structure. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Does This Data Suggest About Ondo InsurTech Insiders?

The fact that there have been no Ondo InsurTech insider transactions recently certainly doesn't bother us. However, our analysis of transactions over the last year is heartening. We'd like to see bigger individual holdings. However, we don't see anything to make us think Ondo InsurTech insiders are doubting the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. At Simply Wall St, we've found that Ondo InsurTech has 6 warning signs (2 make us uncomfortable!) that deserve your attention before going any further with your analysis.

Of course Ondo InsurTech may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.